Healthcare Business News

PLANTATION, FL–(Marketwire – August 24, 2010) –  Transax International Limited (Transax) (OTCQB: TNSX), a network solutions company for healthcare providers and health insurance companies, today reported financial results for the first half of 2010 and second quarter ended June 30, 2010.

For the quarter ending June 30, 2010 Transax generated net revenues of $1,046,429 compared to $1,093,705 in net revenues during second quarter of 2009, a 4% decrease. The decrease in revenue is due to the loss of one minor contract during the second quarter 2010 partly offset by continued growth in real-time transactions and rollout of previously announced contracts. Transaction volume was 2.3 million for the second quarter of 2010 compared to 2.1 million in the same period during 2009.

Loss from operations in the second quarter of 2010 was $418,904 compared with a $243,988 loss during the same period in 2009. Net loss for the second quarter of 2010 was $975,480 compared with a net loss in the second quarter of 2009 of $3,442,588. The decrease in net loss is principally due to a decrease in non cash items related to derivative liabilities expenses.

For the quarter ending June 30, 2010, the Company incurred $1,465,333 in operating expenses compared to $1,337,693 during the same period in 2009. The increase in expenses was attributed to significant increases in cost of product support services together with general and administrative expense increases in complying the Company products to new government regulations in Brazil.

For the six months ended June 30, 2010 revenues increased by 1% to $2,069,261 from $2,046,023 during the same period in 2009. The loss of one customer during the period was partially offset by revenues from new customers during the period. The Company recorded an operational loss of $938,180 for the six months ending June 30, 2010 compared to operational loss of $561,171 for the six months ending June 30, 2009. Net loss for the first six months of 2010 was $1,367,493 compared to a net loss of $3,721,815 for the same period in 2009.

At the end of the second quarter 2009 the Company had over 20,150 solutions installed in Brazil including 3,125 Point of Sales (POS) Solutions, 16,350 operational WEB solutions and 1,870 Interactive Voice Response (IVR) solutions with the balance of PC and Server solutions installed in medical laboratories. During the six month period ending June 30, 2010 the company installed over 5,000 WEB solutions to medical provider locations to support future roll out and revenue growth.

In announcing the results Stephen Walters, President & CEO, stated, “Transaction volumes have increased steadily during 2010 recording a 11% annual increase. The company installed 1,250 solutions during July 2010 and recorded over 850,000 for the month of July 2010. Additional roll out of solutions to increase revenues and reduction in operating costs is the main target of the company for the second half of the year.”

About Transax International Limited

Transax International is an emerging network solutions provider for the healthcare sector. Utilizing its proprietary MedLink™ technology, Transax provides a service similar to credit card processing for the health insurance and providers industries. A transaction consists of: approving eligibility, authorization, auto-adjudication of the health claim and generating the claim payable files — provided instantaneously in “real time” — regardless of method of claim generation.

Transax’s solutions have been proven to significantly decrease health insurance claim expenditures and healthcare provider costs. Based in Plantation, Fl, Transax maintains a major operations office in Rio de Janeiro, Brazil, with approximately 45 staff and a Sales Office in Sao Paulo, Brazil. The Company has contracts in place with major health insurers in Brazil and currently undertakes approximately 800,000 transactions per month.

SAFE HARBOR STATEMENT: “THIS NEWS RELEASE MAY INCLUDE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF SECTION 27A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE UNITED STATES SECURITIES AND EXCHANGE ACT OF 1934, AS AMENDED, WITH RESPECT TO ACHIEVING CORPORATE OBJECTIVES, DEVELOPING ADDITIONAL PROJECT INTERESTS, THE COMPANY’S ANALYSIS OF OPPORTUNITIES IN THE ACQUISITION AND DEVELOPMENT OF VARIOUS PROJECT INTERESTS AND CERTAIN OTHER MATTERS. THESE STATEMENTS ARE MADE UNDER THE ‘SAFE HARBOR’ PROVISIONS OF THE UNITED STATES PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 AND INVOLVE RISKS AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE IN THE FORWARD-LOOKING STATEMENTS CONTAINED HEREIN.”

DALLAS, TX–(Marketwire – August 23, 2010) – Metiscan, Inc., publicly traded under the ticker symbol (PINKSHEETS: MTIZ), announced today that the Company has filed its Registration Statement on Form S-1 with the Securities and Exchange Commission (SEC).

Bryan A. Scott, President and CEO of Metiscan, Inc., commented, “Our SEC Counsel has advised us that our Registration Statement on Form S-1 was filed with the SEC and that the review and comment period has begun. We look forward to working with the SEC to make our registration effective and to become a fully reporting issuer that is traded on the Over-the-Counter Bulletin Board.”

Interested parties may access MTIZ information from the SEC website at www.SEC.gov.

As previously announced, Metiscan will be hosting a nationwide teleconference on Wednesday, September 1, 2010 at 4:15 PM (Eastern Daylight Time) to update the financial community on points of interest that affect Metiscan and its shareholders. Space is limited on the call-in lines for this national teleconference, therefore in order to participate please call 407-389-5900 and ask for investor relations to make a reservation. If you have a particular question for Mr. Scott, Ms. Frieh or Mr. Hart, please email questions in advance to [email protected].

About Metiscan, Inc.

Metiscan, Inc. (Metiscan), (PINKSHEETS: MTIZ), is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Click here to see all recent news from this company

CLIFTON, NJ–(Marketwire – August 20, 2010) – Electronic Control Security, Inc. (OTCBB: EKCS) (ECSI), a global leader in perimeter security systems, today announced receipt of orders totaling $1.1 million for security upgrades at several U.S. Air Force bases and nuclear power stations to meet updated force protection and NRC requirements. In addition, proposals have been submitted for other U.S. Air Force base and nuclear power station upgrades scheduled for fiscal 2011 and 2012.

“These security upgrades have been in the planning stage since 2008 following the terror attacks against our domestic assets in 2001. All branches of government including the nuclear facilities are upgrading and hardening our facilities at an accelerated pace. The NRC has always been one step ahead of potential terrorist threats, and the Department of Defense has increased its efforts in hardening its facilities as well,” commented Arthur Barchenko, President and CEO of ECSI. “Our business is about assisting in the development of security solutions to prevent infiltration of high-value assets and to guard against potential terrorist penetration. We are very proud to be part of this on-going security and anti-terrorism process to help protect the nation’s sensitive and high-visibility sites.” 

These security upgrades include the design and installation of multi-layer security systems including ECSI’s Infrared Perimeter Intrusion Detection (IPID®) system, Fiber Optic Intelligence Detection System (FOIDS®), Intelligent Video Motion Detection (IVMD®) and infrared pan-tilt-zoom camera technology.

About ECSI
ECSI is a global leader in perimeter security and a quality provider to the Department of Defense, Department of Energy, nuclear power stations, and other large commercial-industrial complexes. The Company designs, manufactures and markets physical electronic security systems for high-profile, high-threat environments utilizing risk assessment and analysis to determine and address the security needs of its customers. Teaming agreements with major system integrators enable ECSI to support the installation and aftermarket of its products in the U.S. and overseas. ECSI is located at 790 Bloomfield Avenue, Bldg. C-1, Clifton, NJ 07012. Tel: 973-574-8555; Fax: 973-574-8562. For more information on ECSI and its customers, please visit http://www.ecsiinternational.com.

ECSI INTERNATIONAL, INC. SAFE HARBOR STATEMENT: This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry and reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to changes in economic conditions generally and in our industry specifically, changes in security technology, receipt and timing of collections from purchase orders, legislative or regulatory changes that affect us, the availability of working capital, changes in costs and the availability of goods and services, the introduction of competing products, changes in our operating strategy or development plans, sufficiency of cash reserves and the risks and uncertainties discussed under the heading “RISK FACTORS” in Item 1 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2009 and in our other filings with the Securities and Exchange Commission. We undertake no obligation to revise or update any forward-looking statement for any reason.

CLIFTON, NJ–(Marketwire – August 20, 2010) – Electronic Control Security, Inc. (OTCBB: EKCS) (ECSI), a global leader in perimeter security systems, today announced receipt of orders totaling $1.1 million for security upgrades at several U.S. Air Force bases and nuclear power stations to meet updated force protection and NRC requirements. In addition, proposals have been submitted for other U.S. Air Force base and nuclear power station upgrades scheduled for fiscal 2011 and 2012.

“These security upgrades have been in the planning stage since 2008 following the terror attacks against our domestic assets in 2001. All branches of government including the nuclear facilities are upgrading and hardening our facilities at an accelerated pace. The NRC has always been one step ahead of potential terrorist threats, and the Department of Defense has increased its efforts in hardening its facilities as well,” commented Arthur Barchenko, President and CEO of ECSI. “Our business is about assisting in the development of security solutions to prevent infiltration of high-value assets and to guard against potential terrorist penetration. We are very proud to be part of this on-going security and anti-terrorism process to help protect the nation’s sensitive and high-visibility sites.” 

These security upgrades include the design and installation of multi-layer security systems including ECSI’s Infrared Perimeter Intrusion Detection (IPID®) system, Fiber Optic Intelligence Detection System (FOIDS®), Intelligent Video Motion Detection (IVMD®) and infrared pan-tilt-zoom camera technology.

About ECSI
ECSI is a global leader in perimeter security and a quality provider to the Department of Defense, Department of Energy, nuclear power stations, and other large commercial-industrial complexes. The Company designs, manufactures and markets physical electronic security systems for high-profile, high-threat environments utilizing risk assessment and analysis to determine and address the security needs of its customers. Teaming agreements with major system integrators enable ECSI to support the installation and aftermarket of its products in the U.S. and overseas. ECSI is located at 790 Bloomfield Avenue, Bldg. C-1, Clifton, NJ 07012. Tel: 973-574-8555; Fax: 973-574-8562. For more information on ECSI and its customers, please visit http://www.ecsiinternational.com.

ECSI INTERNATIONAL, INC. SAFE HARBOR STATEMENT: This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry and reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to changes in economic conditions generally and in our industry specifically, changes in security technology, receipt and timing of collections from purchase orders, legislative or regulatory changes that affect us, the availability of working capital, changes in costs and the availability of goods and services, the introduction of competing products, changes in our operating strategy or development plans, sufficiency of cash reserves and the risks and uncertainties discussed under the heading “RISK FACTORS” in Item 1 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2009 and in our other filings with the Securities and Exchange Commission. We undertake no obligation to revise or update any forward-looking statement for any reason.

CLIFTON, NJ–(Marketwire – August 20, 2010) – Electronic Control Security, Inc. (OTCBB: EKCS) (ECSI), a global leader in perimeter security systems, today announced receipt of orders totaling $1.1 million for security upgrades at several U.S. Air Force bases and nuclear power stations to meet updated force protection and NRC requirements. In addition, proposals have been submitted for other U.S. Air Force base and nuclear power station upgrades scheduled for fiscal 2011 and 2012.

“These security upgrades have been in the planning stage since 2008 following the terror attacks against our domestic assets in 2001. All branches of government including the nuclear facilities are upgrading and hardening our facilities at an accelerated pace. The NRC has always been one step ahead of potential terrorist threats, and the Department of Defense has increased its efforts in hardening its facilities as well,” commented Arthur Barchenko, President and CEO of ECSI. “Our business is about assisting in the development of security solutions to prevent infiltration of high-value assets and to guard against potential terrorist penetration. We are very proud to be part of this on-going security and anti-terrorism process to help protect the nation’s sensitive and high-visibility sites.” 

These security upgrades include the design and installation of multi-layer security systems including ECSI’s Infrared Perimeter Intrusion Detection (IPID®) system, Fiber Optic Intelligence Detection System (FOIDS®), Intelligent Video Motion Detection (IVMD®) and infrared pan-tilt-zoom camera technology.

About ECSI
ECSI is a global leader in perimeter security and a quality provider to the Department of Defense, Department of Energy, nuclear power stations, and other large commercial-industrial complexes. The Company designs, manufactures and markets physical electronic security systems for high-profile, high-threat environments utilizing risk assessment and analysis to determine and address the security needs of its customers. Teaming agreements with major system integrators enable ECSI to support the installation and aftermarket of its products in the U.S. and overseas. ECSI is located at 790 Bloomfield Avenue, Bldg. C-1, Clifton, NJ 07012. Tel: 973-574-8555; Fax: 973-574-8562. For more information on ECSI and its customers, please visit http://www.ecsiinternational.com.

ECSI INTERNATIONAL, INC. SAFE HARBOR STATEMENT: This press release contains forward-looking statements that involve substantial uncertainties and risks. These forward-looking statements are based upon our current expectations, estimates and projections about our business and our industry and reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including but not limited to changes in economic conditions generally and in our industry specifically, changes in security technology, receipt and timing of collections from purchase orders, legislative or regulatory changes that affect us, the availability of working capital, changes in costs and the availability of goods and services, the introduction of competing products, changes in our operating strategy or development plans, sufficiency of cash reserves and the risks and uncertainties discussed under the heading “RISK FACTORS” in Item 1 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2009 and in our other filings with the Securities and Exchange Commission. We undertake no obligation to revise or update any forward-looking statement for any reason.

DALLAS, TX–(Marketwire – August 19, 2010) – Metiscan, Inc. (PINKSHEETS: MTIZ) is pleased to announce that the Company will be hosting a nationwide teleconference on Wednesday, September 1, 2010 at 4:15 PM (Eastern Daylight Time) to update the financial community on points of interest that affect Metiscan and its shareholders. The Company will be discussing its recent operational accomplishments that have transpired over the previous six months as well as providing insight into objectives Metiscan has outlined for the near term.

The nationwide teleconference will be hosted and moderated by Marc Jablon, CEO of Big Apple Consulting USA. The featured speakers for Metiscan will be Bryan Scott, President, CEO & Director, Janine Frieh, CFO & Director, and Brian Hart, COO & Director.

Space is limited on the call-in lines for this national teleconference, therefore in order to participate please call 407-389-5900 and ask for investor relations to make a reservation. If you have a particular question for Mr. Scott, Ms. Frieh or Mr. Hart, please email questions in advance to [email protected].

“This venue is a great platform for us to share information with our shareholders and discuss Metiscan’s story,” stated Bryan A. Scott, CEO & President of Metiscan, Inc.

About Metiscan, Inc.

Metiscan, Inc. (Metiscan), OTCPK: MTIZ, is the parent company of a portfolio of enterprises with operations in healthcare, healthcare IT, mobile technology and employment services. Metiscan manages all aspects of its subsidiaries and is currently pursuing acquisitions that complement its subsidiaries’ operations. Metiscan’s subsidiaries include FirstView EHR, Inc., Taptopia, Inc., Schuylkill Open MRI, Inc., Shoreline Employment Services, Inc. For more information visit www.metiscan.com

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan’s actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law. 

Click here to see all recent news from this company

NEW YORK, NY–(Marketwire – August 19, 2010) –  Allied Healthcare International Inc. (NASDAQ: AHCI) (AIM: AHI), a leading provider of flexible healthcare staffing services in the United Kingdom, announced today that G. Richard Green has tendered his resignation as a member of the Company’s Board of Directors for personal reasons, effective August 21, 2010. Mr. Green has been a director of Allied since 1998 and recently served on the Nominating and Corporate Governance Committee of the Board.

The Company also announced that Professor Raymond John Playford has been appointed to the Board of Directors of Allied, effective August 21, 2010. Prof. Playford, age 50, has served as Medical Advisor to the Board of Allied since June 2010.

Dr. Jeffrey S. Peris, Chairman of the Board of Allied Healthcare International Inc., commented, “Richard has served with distinction on our Board. His intellect, depth of business knowledge and leadership experience have contributed greatly to Allied’s growth and success throughout his long tenure as our director. On behalf of the entire Board, senior management team and employees of Allied, we want to wish Richard years of health and happiness.”

Dr. Peris also stated, “Ray has already made many valuable contributions since he joined us as Medical Advisor, and we welcome him to the Board to further assist us in augmenting the growth strategies of our Company. His wealth of clinical, healthcare and NHS expertise will both support our commitment to providing our customers with one of the highest levels of quality care in our industry and to enhancing the market leadership of Allied.”

Prof. Playford has more than 25 years of experience in the medical field, specializing in clinical research. He is currently Deputy Warden and Professor of Medicine at Barts and the London School of Medicine and Dentistry, as well as Vice Principal (NHS Liaison), Queen Mary, University of London. Prof. Playford is also a Non-Executive Director of Barking, Havering and Redbridge NHS Trust and a director of Repair and Protection Foods Ltd., which is engaged in food research. He has also been an advisor to both the UK Government and the healthcare industry.

Prof. Playford received a Medical degree (M.B., B.S.) in 1978 from St. Bartholomew’s Medical School and his PhD in 1992 from the Royal Postgraduate Medical School at Imperial College, London. He is a Fellow of the Royal College of Physicians (UK) and the Royal College of Pathologists (UK) and was Visiting Professor, Harvard Medical School and Massachusetts General Hospital in 2002. He has published over 100 original scientific and clinical papers and received several awards for research including the British Society of Gastroenterology (BSG) Sir Francis Avery Jones Research Medal in 1995 and Canadian Alberta Heritage Foundation for Medical Research in 2004. He was made a Fellow of the Academy of Medical Scientists in 2002 and, as a result of his contribution to public education on health matters, became a Fellow of the Royal Society of Arts in 2000.

There are no further disclosures regarding Prof. Playford that are required to be set forth in this press release under the AIM rules.

About Allied Healthcare International Inc.

Allied Healthcare International Inc. is a leading provider of flexible healthcare staffing services in the United Kingdom. Allied operates a community-based network of approximately 115 branches with the capacity to provide carers (known as home health aides in the U.S.), nurses, and specialized medical personnel to locations covering approximately 90% of the U.K. population. Allied meets the needs of private patients, community care, nursing and care homes, and hospitals. For more news and information please visit: www.alliedhealthcare.com.

Forward-Looking Statements

Certain statements contained in this news release may be forward-looking statements. These forward-looking statements are based on current expectations and projections about future events. Actual results could differ materially from those discussed in, or implied by, these forward-looking statements. Factors that could cause actual results to differ from those implied by the forward-looking statements include: general economic and market conditions; the effect of the change in the U.K. government and the impact of proposed changes in recent policy making related to health and social care that may reduce revenue and profitability; Allied’s ability to continue to recruit and retain flexible healthcare staff; Allied’s ability to enter into contracts with local government social services departments, NHS Trusts, hospitals, other healthcare facility clients and private clients on terms attractive to Allied; the general level of demand for healthcare and social care; dependence on the proper functioning of Allied’s information systems; the effect of existing or future government regulation of the healthcare and social care industry, and Allied’s ability to comply with these regulations; the impact of medical malpractice and other claims asserted against Allied; the effect of regulatory change that may apply to Allied and that may increase costs and reduce revenues and profitability; Allied’s ability to use net operating loss carry forwards to offset net income; the effect that fluctuations in foreign currency exchange rates may have on our dollar-denominated results of operations; and the impairment of goodwill, of which Allied has a substantial amount on the balance sheet, may have the effect of decreasing earnings or increasing losses. Other factors that could cause actual results to differ from those implied by the forward-looking statements in this press release include those described in Allied’s most recently filed SEC documents, such as its most recent annual report on Form 10-K, all quarterly reports on Form 10-Q and any current reports on Form 8-K filed since the date of the last Form 10-K. Allied undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. 

IRVINE, CA–(Marketwire – August 18, 2010) –  Sun Healthcare Group, Inc. (NASDAQ: SUNH) today announced the closing of its previously announced underwritten public offering of 26,750,000 shares of its common stock, as well as the closing of the underwriters’ over-allotment option to purchase an additional 4,012,500 shares of common stock. The net proceeds of the offering, after giving effect to the issuance and sale of all 30,762,500 shares of common stock at a price to the public of $7.75 per share, were approximately $224.8 million after deducting the underwriting discount and estimated offering expenses. Sun intends to use the net proceeds from the offering to repay a portion of the outstanding term loans under its existing credit facility.

Richard K. Matros, Sun’s chairman and chief executive officer, commented, “We are pleased with the response to the equity offering, which provides us the ability to pay down a significant portion of our indebtedness. Following the success of this offering, we are looking forward to completion of the proposed separation of our operating businesses and our real estate assets.”

This press release does not constitute an offer to sell or a solicitation of any offer to buy the shares of Sun’s common stock described herein, nor shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

The prospectus supplement and the related prospectus relating to the offering may be obtained by written request to Jefferies & Company, Inc., Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 12th Floor, New York, NY 10022; by telephone at (877) 547-6340; or by e-mail at [email protected]; or Credit Suisse Securities (USA) LLC, Attention: Credit Suisse Prospectus Department, One Madison Avenue, New York, NY 10010 or by telephone at (800) 221-1037.

About Sun Healthcare Group, Inc.

Sun Healthcare Group, Inc.’s (NASDAQ: SUNH) subsidiaries provide nursing, rehabilitative and related specialty healthcare services principally to the senior population in the United States. Sun’s core business is providing, through its subsidiaries, inpatient services, primarily through 166 skilled nursing centers, 16 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and eight mental health centers. On a consolidated basis, Sun has annual revenues of $1.9 billion and approximately 30,000 employees in 46 states. At June 30, 2010, SunBridge centers had 23,209 licensed beds located in 25 states, of which 22,427 were available for occupancy. Sun also provides rehabilitation therapy services to affiliated and non-affiliated centers through its SunDance subsidiary, medical staffing services through its CareerStaff Unlimited subsidiary and hospice services through its SolAmor subsidiary. 

Forward-Looking Statements

Statements made in this release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “hope,” “intend,” “may” and similar expressions. Factors that could cause actual results to differ are identified in the public filings made by the Company with the Securities and Exchange Commission and include our ability to complete the separation of our operating businesses and our real estate assets. More information on factors that could affect our business and financial results are included in our public filings made with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun’s web site, www.sunh.com. The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control. We caution investors that any forward-looking statements made by Sun are not guarantees of future performance. We disclaim any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

VICTORIA, BRITISH COLUMBIA–(Marketwire – Aug. 18, 2010) – GrowthPoint Capital Corp. (“GrowthPoint”) is issuing this press release pursuant to the early warning requirements of applicable securities laws in Canada with respect to Vigil Health Solutions Inc. (“Vigil”).

Pursuant to a private agreement, on July 27, 2010, GrowthPoint acquired ownership of $100,000 in debt which is convertible into, subject to adjustment, 1,000,000 common shares of Vigil at a conversion price of $0.10 per common share, representing approximately 1.0% of Vigil’s outstanding common shares.

Following this transaction, in addition to the $100,000 in convertible debt which if converted would represent approximately 1.0% of Vigil’s outstanding common shares, GrowthPoint and its affiliates also hold 9,929,000 common shares representing approximately 9.9% of Vigil’s outstanding common shares; 650,000 Deferred Stock Units representing approximately 0.7% of Vigil’s outstanding common shares; and 744,000 Stock Options representing approximately 0.7% of Vigil’s outstanding common shares. In aggregate, assuming the full exercise and conversion of the aforementioned securities, GrowthPoint and its affiliates would hold approximately 12.3% of the issued and outstanding common shares of Vigil.

In addition to owning or exercising control over the Vigil securities through GrowthPoint Capital Corp., GrowthPoint acts jointly or in concert with Greg Peet and GrowthPoint Ventures (VCC) Corp.

GrowthPoint acquired these securities for investment purposes. GrowthPoint may, depending on market conditions and other factors as well as applicable securities laws, acquire additional securities of Vigil through the facilities of the TSX Venture Exchange, private agreements or otherwise. At the current time, however, GrowthPoint does not intend to acquire more than 19.99% of the outstanding common shares of Vigil (assuming full exercise or conversion of any securities of Vigil that GrowthPoint may acquire). GrowthPoint may, depending on market conditions, sell any or all of its common shares of Vigil.

For additional information, or for a copy of the early warning report filed in respect of the above transaction, please see contact information below.

TULSA, OK–(Marketwire – August 18, 2010) –  MacroSolve, Inc. (OTCBB: MCVE), a leading provider of mobile business solutions, announced today that its patent-pending ReForm XT™, has been selected by Orthopedic Resources, a growing medical products distributor, for its wireless inventory and order tracking platform. 

Tulsa, Oklahoma-based Orthopedic Resources is a rapidly growing distributor of Durable Medical Equipment. The company has more than 50 national and regional insurance contracts and services the southwestern and mid-western United States.

Mark Farrow, President of Orthopedic Resources, commented, “In order to support the tremendous growth in sales we’ve experienced, we decided it was time for us to move from mainly paper-based inventory and order systems to a mobile solution. ReForm XT is the right product for us. It will help our growing sales force of over 50 people provide superior service to the 250-plus hospitals we serve. ReForm XT will help us meet our goals to automate, expand and create efficiencies.”

MacroSolve president and CEO Clint Parr added, “ReForm XT is an incredibly flexible mobile tool that is the right solution for high-growth companies like Orthopedic Resources. From inventory and ordering to a more diverse set of mobility applications, ReForm XT has been selected once again as the solution of choice by smart companies.”

ReForm XT is a powerful resource that can operate within any industry. Creating a mobile application to automate business processes helps save time, decrease errors, increase productivity and delivery of up to the minute information to save businesses money and increase revenues. For more on ReForm XT please visit http://www.goanyware.com/products/reformxt/.

For information regarding Orthopedic Resources please visit www.orthopedicresources.com.

About MacroSolve
MacroSolve, Inc. is a pioneer in delivering mobile apps and solutions to businesses and government. Founded in 1997, the company has an extensive network including the top name brands in wireless hardware and software as well as carriers. MacroSolve’s mission is to become the leader in delivering mobile business apps, a market projected to grow by double digits to $11.6 B by 2012. The company operates through its subsidiaries including Anyware Mobile Solutions (http://www.goanyware.com/). For more information, visit http://www.macrosolve.com/ or call 800-401-8740.

Safe Harbor Statement
 This press release contains projections of future results and other forward-looking statements that involve a number of risks and uncertainties and are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Important factors that may cause actual results and outcomes to differ materially from those contained in the projections and forward-looking statements included in this press release are described in our publicly filed reports. Factors that could cause these differences include, but are not limited to, the acceptance of our products, lack of revenue growth, failure to realize profitability, inability to raise capital and market conditions that negatively affect the market price of our common stock. The Company disclaims any responsibility to update any forward-looking statements.

Click here to see all recent news from this company

LOS ANGELES, CA–(Marketwire – August 16, 2010) –  MMRGlobal, Inc. (OTCBB: MMRF) (jointly, “the Company” and “MMR”) (www.mmrglobal.com) today filed its quarterly statement for the six months ended June 30, 2010.

Revenues for the first six months from sales of the Company’s consumer and professional products, MyMedicalRecords, MyEsafeDepositBox and MMRPro, were up by 58.6% over 2009. Total sales for these products, including Deferred Revenue (the portion of the Company’s sales that is to be recognized monthly over the term of agreements with our customers), have increased by 94%. Total Revenues for the three months ended June 30, 2010, including the Company’s core products and licensing fees, were up by 21% as compared to 2009. Total sales for the same period, including Deferred Revenue, were up 60.7% as compared to 2009.

According to Ingrid Safranek, the Company’s Chief Financial Officer, “We reduced total liabilities by $2.4 million or 28.5%. In addition, we reduced Accounts Payable by $451 thousand or 15%. Although we disclosed an Accounts Payable balance of $2.5 million, $1.6 million of that balance is attributable to the reverse merger with Favrille, Inc. and only $272 thousand represents MMR trade payables necessary to operations. Accordingly, we maintain good relationships with our vendors.”

Safranek continued, “In the last quarter, we were able to issue equity in lieu of cash to reduce liabilities by $1 million. We plan on using our equity to further reduce liabilities and strengthen our balance sheet based on our vendors’ belief in the value of the Company. Our ability to issue equity for services has afforded us the opportunity to support sales of MMRPro and other advertising and marketing programs as well as continuing to exploit patent opportunities with our biotech assets. Only $1.2 million of our loss was cash-related. The remaining amount represents non-cash expenses driven by $5.6 million from the application of accounting principles to value derivative liabilities and equity as well as an additional $1.0 million from stock options, warrants and common stock issued for services. These warrants and stock options have enabled us to obtain services that a Company our size would not otherwise have been able to afford.”

According to Robert H. Lorsch, Chairman and CEO of MMRGlobal, “We are well on our way toward executing on our business plan to achieve a global footprint from which we will sell our proprietary line of Personal Health Record (www.mmrvideos.com) and MyEsafeDepositBox (www.myesafevideos.com) products and MMRPro professional medical record products and services (www.mmrprovideos.com). However, growing a technology company in health care costs money. Accordingly, we are incurring increasing costs necessary to our growth. For example, we are now deploying development teams both in the U.S. and China to support the UNIS-TongHe transaction.” 

“We are also expanding technical and development resources at home with increased staff in support of MMRPro,” said Lorsch. “This includes adding resources necessary to provide services that will meet meaningful use criteria and enable customers who use our products to qualify for government stimulus around the world. In addition, we are relocating our most experienced development resources to the U.S. from Nihilent headquarters in India to work with our management team and our customers directly.”

“Also, I plan on being in India in October for the launch of a Nihilent and MMRGlobal joint sales effort to small-sized health care professionals, hospitals and the government in India. At the same time, we are also increasing the size of our processing, hosting and IT infrastructure, adding more feature-rich facilities designed to reduce cost and increase scalability which should ultimately improve margins,” added Lorsch.

The Company has also begun the process of spending significantly more money on advertising, marketing and sales promotion using television (www.mmrontv.com) the web and through affiliate partnerships. An example is the “$25.00 Check-Up” refund program which launched on the Company’s MyMedicalRecords.com website today. 

MMR is also in the process of upgrading MMRPro (www.mmrprovideos.com), the Company’s professional document imaging and management system for health care professionals. For instance, recently added features enable forms to be customized to an existing office practice resulting in the ability to access customized forms from MMRPro on demand. As such, doctors are able to use the forms they use today and still continue to move toward meaningful use.

Additionally, the Company is working with several major hospital groups to help market MMRPro systems to doctors associated with these specific hospital groups. This is part of a program designed to help monetize MMRPro patient upgrades. Also, MMR is starting to call on physician offices in the United States through the Kodak nationwide reseller channel.

Patient upgrades enable health care professionals to take advantage of the MMRPro “Stimulus Program” (http://mmrvideos.com/stimulus). This program creates a revenue stream for physicians from patient upgrades. The Company believes that its Stimulus Program can generate more than twice the $44,000 in revenue for physicians than the government’s HITECH Act stimulus program in much less time.

The Company continues to actively explore opportunities with its pre-merger Favrille biotech assets. In association with GRSworldwide, MMRGlobal is working to bring its anti-CD20 monoclonal antibodies to market. These antibodies are potentially useful in treating B-Cell malignancies, including Non-Hodgkin’s Lymphoma (NHL) and additional B-Cell mediated conditions such as rheumatoid arthritis. MMR’s anti-CD20 antibody asset is potentially a candidate for a next generation of Rituximab, marketed under the trade name Rituxan® in the United States by Biogen Idec and Genentech (wholly owned member of the Roche Group) and under the name MabThera® by Roche in the rest of the world except Japan, where it is co-marketed by Chugai and Zenyaku Kogyo Co. Ltd. Rituxan/MabThera is one of the world’s most successful monoclonal antibodies with reported total sales in 2009 in excess of US$5.6 billion.

MMRGlobal also continues to pursue various national phase filings from the Patent Cooperation Treaty patent application directed to the anti-CD20 monoclonal antibodies, including in the United States, Australia, Brazil, Canada, China, Europe, India, Japan, South Korea and Mexico. The Company has further been addressing opportunities pertaining to intellectual property rights involving B and T cell vaccine technology relative to the FavID vaccine in various stages in the United States and foreign countries through its reverse merger with Favrille. MMRGlobal is also in the process of filing certain patents regarding numerous aspects of the FavID vaccine, a portion of which has been recently granted. 

The Company continues its activities in support of the launch of the Chartis-branded MyEsafeDepositBox product, which plans to provide MMR’s secure online virtual safe and Personal Health Record products and services to Chartis policyholders worldwide, while it further works with Chartis on opportunities to offer its products domestically as well.

Additionally, MMRGlobal is in active negotiations with one of the world’s largest financial institutions regarding the development of paperless loan processing and delivery solutions whereby loan documents can be delivered electronically through the Company’s MyEsafeDepositBox product, with resultant completed documents being filed in a permanent online MyEsafeDepositBox account.

“We are pursuing several Merger and Acquisition opportunities that could accelerate growth, expand the Company’s product line and enable us to offer more services consistent with criteria for meaningful use, specifically PHR and EMR related,” Lorsch added. “We have always intended to grow MMR into a much larger organization. However, it takes money and patience to grow a company. For example, Amazon went public in 1997, and had a net loss of $31 million, followed by a net loss of $125 million, and almost $720 million in 1998 and 1999, respectively. In their last annual report for the year ended 2009, they had net income of $902 million.”

About MMRGlobal, Inc.
MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheater.com.

Forward Looking Statement
Statements in this press release that are not strictly historical in nature constitute “forward-looking statements.” Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” and “continue,” or the negative of these words. Any comparisons made with other companies are for illustrative purposes only and do not imply any similar levels of growth, revenue, or income. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company’s products are not adopted or viewed favorably by the health care community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; variations in our quarterly operating results; timing and volume of sales and installations; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the health care industry; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; acceptance of the Company’s marketing and promotional campaigns; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company’s filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. 

Click here to see all recent news from this company

LONDON, ENGLAND–(Marketwire – Aug. 16, 2010) – IDBS, the leading worldwide provider of data management and analytics solutions to R&D and healthcare organisations, announces that, as the result of continuing expansion, and growth in demand for its products and services, revenues for the six months ended 30 June 2010 rose by 20% on the same period of 2009 to $20.3 million, with profit before tax also growing strongly.

These results follow the excellent progress made in 2009, for which IDBS reported 12% revenue growth to $36.4 million, with the company sustaining healthy underlying profitability and margins and completing the cash acquisition of InforSense in June 2009.

Excluding the impact of InforSense, underlying revenue growth was well into double digits with underlying profit before tax significantly up on the first half of last year. This reflects growing and recurring revenues from existing customers as well as projects completed for new customers.

Revenue for the first half of 2010 benefited from a strong product performance in the company’s core pharmaceuticals market where organisations are seeking to improve the effectiveness of their business processes and the use of high-value data. Key to growth for the period was the implementation of significant projects, involving the E-WorkBook Suite, at a number of major companies for drug formulation and preclinical development, and at a contract manufacturer of biologics for process development improvement.

Software sales for the period grew by 44% on the first half of 2009 with maintenance revenues increasing by 13% and professional services by 25%.

Since the acquisition of InforSense, IDBS has established a leading position in the high-growth market of biomarker and personalised medicine research, recently winning a number of new contracts which will benefit the second half of 2010 and beyond. These include a significant engagement with Barts Hospital and the London NHS Trust to improve the understanding of cardiovascular disease in the UK.

“R&D companies and healthcare organisations recognise the strategic value of IDBS in process improvement projects, enhancing regulatory compliance and research collaboration,” commented Neil Kipling, founder and CEO of IDBS. “Our reputation and market leadership are based on our data management expertise and solutions combined with an unrivalled understanding of scientists, the R&D process and the needs of our customers. We are continuing to invest in the business and to strengthen our relationships with existing and new customers. As a result, we are confident that IDBS is on track to achieve its best ever financial performance in 2010 and to continue to make strong progress thereafter.”

During the period, IDBS was included in the 2010 ProfitTrack100 list of private companies, recognising the company’s long-term record of sustained, profitable growth.

About IDBS

IDBS is a unique, global supplier of innovative data management and first-in-class analytics solutions which increase efficiency, reduce costs and improve the productivity of Healthcare R&D organisations. Multinational pharmaceutical companies, major public-private healthcare partnerships, global leaders in academic study and high tech companies employ IDBS as a strategic supplier of scientific informatics and business process improvement solutions. IDBS is clearly differentiated from other providers by its unique combination of deep domain knowledge across the entire R&D sector: from the examination of the human genome at the scientist’s bench, through the clinic, to translational medicine initiatives and pay-for-performance healthcare monitoring. IDBS solutions support the protection of Intellectual Property and the requirements for data quality and security demanded under Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP) and HL7 (Health Level) standards. IDBS improves organisational efficiency, releases the value stored in organisations’ R&D data assets and enables effective collaboration through secure scientific data sharing.

IDBS is a ProfitTrack 100 private company, founded in 1989 and headquartered in Guildford, UK. IDBS has worldwide consulting and support presence, with U.S. offices in California, New Jersey and Massachusetts, as well as the EU, Australia and China. Further information can be found at www.idbs.com.

DEURLE, BELGIUM–(Marketwire – August 16, 2010) –  Remedent, Inc. (OTCBB: REMI), an international company specializing in research, development, and manufacturing of oral care and cosmetic dentistry products, reported results for the first quarter ended on June 30, 2010 (in US Dollars).

Net sales for three months ended June 30, 2010 increased 62% to $3.4 million compared to $2.1 million for the same year ago quarter. The increase in sales was due to the inclusion of our Asian retail operations as well as the sale of First Fit.

Profit for the three months ended June 30, 2010 prior to outside shareholders participation totaled approximately $568 thousand compared with losses of $488 thousand for the same year ago quarter. Profits attributed to Remedent common stockholders for three months ended June 30, 2010 was $312 thousand compared to losses of $549 thousand for the same year ago quarter.

Cash and cash equivalents totaled $1.2 million at June 30, 2010 as opposed to $613 thousand as reported at March 31, 2010.

Management Commentary

“The shifting of our business model from wholesale (B2B) model via a distributor to a direct retail model is beginning to bear fruit as previously mentioned during prior conference calls. During the current quarter we included our retail Asian operations of approximately $600 thousand in gross revenues as we are continuing to open new Spa locations in both Europe and Asia during the next quarter and in the remainder of our financial year. Sales in all our Spa locations continue to exceed our expectations as sales continue to climb,” said Guy De Vreese the CEO of Remedent.

Conference Call Information

Remedent will host a conference call on Wednesday, August 18, 2010 at 11:00 a.m. Eastern Standard time (8:00 a.m. Pacific time) to discuss these results and its strategic plans for the future. A question and answer session will follow management’s presentation. To participate in the call, dial the appropriate number 5-10 minutes prior to the start time.

Date: Wednesday, August 18, 2010
Time 11:00 a.m. Eastern time (8:00 a.m. Pacific time).
Dial in number: 888-765-5547
Passcode: 4258061

The replay of the call will be available through September 15, 2010. The dial in number for the replay is 888-203-1112 and the replay pass code is 4258061

About Remedent

Remedent, Inc. specializes in the research, development, manufacturing and marketing of oral care and cosmetic dentistry products. The company serves professional dental industry with breakthrough technology for dental veneers. These products are supported by a line of professional veneer whitening and teeth sensitivity solutions. Headquartered in Belgium, Remedent distributes its products to more than 35 countries worldwide. For more information, go to www.remedent.com.

Statement under the Private Securities Litigation Reform Act of 1995
Statements in this press release that are “forward-looking statements” are based on current expectations and assumptions that are subject to risks and uncertainties. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent’s actual operating results to be materially different from any historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements that explicitly describe these risks and uncertainties, readers are urged to consider statements that contain terms such as “believes,” “belief,” “expects,” “expect,” “intends,” “intend,” “anticipate,” “anticipates,” “plans,” “plan,” “projects,” “project,” to be uncertain and forward-looking. Actual results could differ materially because of factors such as Remedent’s ability to achieve the synergies and value creation contemplated by the proposed transaction. For further information regarding risks and uncertainties associated with Remedent’s business, please refer to the risk factors described in Remedent’s filings with the Securities and Exchange Commission, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q.

NORMAN, OK–(Marketwire – August 16, 2010) – Access Plans, Inc. (OTCBB: APNC), a leading membership benefits marketing company, today announced its operating results for the third quarter and first nine months of FY2010. An investor conference call is scheduled for 11:30 a.m. EDT today, August 16, 2010 (see details below).

Third Quarter Results

Revenues for the three months ended June 30, 2010 increased 3% to approximately $14.4 million, compared with approximately $14.0 million in the third quarter of FY2009. Operating income increased 7% to $1.34 million, versus $1.26 million in the prior-year period.

Net income for the third quarter of FY2010 improved to $0.95 million, which represented an increase of 10% when compared with net income of $0.86 million in the year-earlier quarter. Earnings per share, fully diluted, increased 25% to $0.05, versus $0.04 in last year’s third quarter. The number of weighted average diluted shares outstanding approximated 19.8 million during the most recent quarter, compared with 21.6 million shares in the third quarter of FY2009. The decrease in the weighted average number of diluted shares outstanding resulted from the Company’s repurchase in the first quarter of FY2010.

“I am confident that we are taking the steps necessary to grow our revenues and earnings on a long-term basis,” commented Danny Wright, Chief Executive Officer of Access Plans, Inc. “The Wholesale Plans division generated a 15% increase in revenues during the most recent quarter, reflecting increased customer participation at existing locations, along with an increase in the number of locations offering our plans. The Retail Plans division’s growth continues to more than offset the revenue losses from the run-off of legacy programs that we inherited following the acquisition of Access Plans USA in April 2009. We are also investing in new product offerings and marketing strategies in the Retail Plans division. Meanwhile, we continue to work on transitioning the Insurance Marketing division’s sales mix from its previous emphasis on major medical policies towards innovative solutions that combine supplemental and life products with major medical sales. We believe this new approach, which was prompted by certain aspects of the Healthcare Reform Act, should maintain commission income for agents, while improving the division’s operating margins. We are in the final stages of designing this new supplemental offering, and rollout is scheduled for the first quarter of Fiscal 2011.”

Wholesale Plans

Revenues at the Wholesale Plans division increased 15% to $5.8 million in the most recent quarter, versus $5.0 million in the prior-year period. The increase was attributable to improved sell-through at existing locations, as well as the addition of new accounts. Gross margin doubled to $1.8 million, compared with $0.9 million a year earlier, due to the revenue increase and a reduction in involuntary unemployment waiver expenses resulting from lower levels of national unemployment. Operating income at the division increased 169% to $1.4 million, versus $0.5 million in the prior-year period. 

Retail Plans

Revenues at the Retail Plans division in the third quarter of FY2010 increased 9% to $4.9 million, prior to inter-company eliminations, versus $4.5 million in the prior-year period. The increase was attributable primarily to investments in new programs that offset revenue declines in the legacy business. Gross margins decreased $0.6 million due to upfront sales and marketing costs associated with a new product rollout. The division’s operating income declined to $0.4 million in the third quarter of FY2010, versus $0.9 million in the third quarter of FY2009, as a result of expenses related to a new product rollout, as discussed above.

Insurance Marketing

Insurance Marketing division revenues decreased to $5.0 million, versus $5.7 million in the third quarter of FY2009. The decline was due in large part to the exit of two major medical carriers from the market. Operating income (loss) decreased to ($0.05 million), versus $0.1 million in last year’s third quarter. As discussed above, due to the recent passage of the Health Care Reform Act, our Insurance Marketing division, AHCP, will shift its product mix over the next several quarters to emphasize association-based supplemental insurance products and membership plans offered in conjunction with individual health insurance policies.

Nine-Month Results

Revenues for the nine months ended June 30, 2010 increased 61% to approximately $41.1 million, compared with approximately $25.5 million in the first nine months of FY2009. Operating income increased 35% to $4.2 million, versus $3.1 million in the prior-year period.

Net income for the first nine months of FY2010 increased to $2.6 million, which represented an improvement of 20% when compared with net income of $2.1 million in the corresponding period of the previous fiscal year. On a diluted per-share basis, earnings remained at $0.13 for the nine months ended June 30, 2010 and 2009. The number of weighted average diluted shares outstanding increased to 20.1 million during the first nine months of FY2010, versus 16.5 million in the year-earlier period. 

Other Matters

Cash, cash equivalents and restricted cash totaled $5.1 million at June 30, 2010, versus $4.6 million at September 30, 2009. The modest increase resulted from a $1.0 million note payoff in the second fiscal quarter and higher upfront sales commissions on a new product in the Retail Plans division. The Company has no long-term debt outstanding. Meanwhile, stockholders’ equity has increased 33% from $10.2 million on June 30, 2009 to $13.6 million on June 30, 2010.

Conference Call and Webcast Information

Access Plans will host a conference August 16, 2010 at 11:30 a.m. EDT. To access the conference call, please dial 877-317-6789 (U.S.) or 412-317-6789 (international) and ask to be placed into the “Access Plans” conference call. The conference call will also be available via “live” webcast under the Investor Relations section of the Company’s website at www.accessplans.com, or by visiting http://www.videonewswire.com/event.asp?id=71766 to access the webcast directly.

A replay of the conference call will be available through August 24, 2010 and can be accessed by dialing 877-344-7529 (U.S.) or 412-317-0088 (international) and entering the conference ID number 443633. An archived version of the webcast will also be available under the Investor Relations section of the Company’s website at www.accessplans.com.

About Access Plans, Inc.

Access Plans, Inc. (OTCBB: APNC) is a leading membership benefits marketing company with two distribution channels. The Wholesale/Retail Plans distribution channel specializes in turnkey, private-label membership benefit plans that provide discount products and services, protection benefits and retail services to more than one million customers in the United States and Canada. America’s Health Care Plans (AHCP), the Company’s Insurance Marketing distribution channel, is one of the nation’s largest independent agent networks and provides major medical, life and supplemental insurance products to individuals. For more information, please visit: www.accessplans.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act:

This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, Section 27A of the Securities Act of 1933, as amended and pursuant to the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may relate to financial results and plans for future business activities, and are thus prospective. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are competitive pressures, loss of significant customers, the mix of revenue, changes in pricing policies, delays in revenue recognition, lower-than-expected demand for the Company’s products and services, general economic conditions, and the risk factors detailed from time to time in the Company’s periodic reports and registration statements filed with the Securities and Exchange Commission. Any forward-looking statements are made pursuant to the Private Securities Litigation Reform Act of 1995 and the Company assumes no responsibility for updating such forward-looking statements after the date of this release.

LOS ANGELES, CA–(Marketwire – August 13, 2010) – MMRGlobal, Inc. (OTCBB: MMRF) (www.mmrglobal.com) today announced it will release financial results for the second quarter ended June 30, 2010 after the close of market on Monday, August 16, 2010. The Company expects to exceed expectations for the first six months of 2010.

“We are continuing to execute on our business plan, expanding globally, moving offices, and doubling the size of our IT infrastructure in the United States while deploying development resources in China,” said Robert H. Lorsch, Chairman and CEO of MMRGlobal. “We’re excited about the interest in MyEsafeDepositBox from financial institutions. We are actively involved in pursuing M&A opportunities in our core business of personal and electronic health records and patent opportunities with our biotech assets. Additionally, next week we will launch the first-ever online promotion program to consumers designed to encourage them to better health by activating a MyMedicalRecords Personal Health Record account (www.mmrvideos.com). MMRGlobal is an entrepreneurial company, and like a NASA where many commercial products and services are a byproduct of its core space missions, we believe our technologies can generate many ways to provide life-saving tools that can be offered to a variety of business and industries. Although we began with Personal Health Records, we continue to develop new products and relationships, such as with Kodak and Chartis International.”

The Company believes that the restructuring of the healthcare system in the United States will continue to present ongoing opportunities for uses of its products and services to consumers, healthcare professionals and corporations.

About MMRGlobal, Inc.
MMR Global, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. (“MMR”), provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user’s account. The Company’s professional offering, MMRPro, is designed to give physicians’ offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. MMR is also an integrated service provider on Google Health. To learn more about MMR Global, Inc. and its products, visit www.mymedicalrecords.com and view the videos at www.mmrtheater.com.

Forward-Looking Statements
Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as “need,” “possibility,” “offer,” “development,” “if,” “negotiate,” “when,” “begun,” “believe,” “achieve,” “will,” “estimate,” “expect,” “maintain,” “plan,” and “continue.” MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements are based on MMRGlobal, Inc.’s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related to changes in MMRGlobal, Inc.’s business prospects, results of operations or financial condition, government regulation, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.’s public filings with the U.S. Securities and Exchange Commission.

Click here to see all recent news from this company

IRVINE, CA–(Marketwire – August 13, 2010) –  Sun Healthcare Group, Inc. (NASDAQ: SUNH) today announced the pricing of an underwritten public offering of 26,750,000 million shares of its common stock at a price to the public of $7.75 per share. Sun has granted the underwriters a 30-day option to purchase up to 4,012,500 additional shares of its common stock to cover over-allotments, if any. Sun expects to receive net proceeds, after deducting the underwriting discount and estimated offering expenses, of approximately $195.3 million from the offering, or $224.8 million if the underwriters exercise their over-allotment option in full. The offering is expected to close on Aug. 18, 2010, subject to customary closing conditions.

Sun intends to use the net proceeds from this offering to repay a portion of the outstanding term loans under its existing credit facility.

Jefferies & Company, Inc., Credit Suisse Securities (USA) LLC and J.P. Morgan Securities Inc. are the joint book-running managers for this offering.

This press release does not constitute an offer to sell or a solicitation of any offer to buy the shares of Sun’s common stock described herein, nor shall there be any offer, solicitation or sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. The offering may be made only by means of the prospectus supplement and the related prospectus relating to the offering, copies of which may be obtained by written request to Jefferies & Company, Inc., Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 12^th Floor, New York, NY 10022, by telephone at (877) 547-6340, or by e-mail at [email protected]; or Credit Suisse Securities (USA) LLC, Attention: Credit Suisse Prospectus Department, One Madison Avenue, New York, NY 10010 or by telephone at (800) 221-1037.

About Sun Healthcare Group, Inc.

Sun Healthcare Group, Inc.’s (NASDAQ: SUNH) subsidiaries provide nursing, rehabilitative and related specialty healthcare services principally to the senior population in the United States. Sun’s core business is providing, through its subsidiaries, inpatient services, primarily through 166 skilled nursing centers, 16 combined skilled nursing, assisted and independent living centers, 10 assisted living centers, two independent living centers and eight mental health centers. On a consolidated basis, Sun has annual revenues of $1.9 billion and approximately 30,000 employees in 46 states. At June 30, 2010, SunBridge centers had 23,209 licensed beds located in 25 states, of which 22,427 were available for occupancy. Sun also provides rehabilitation therapy services to affiliated and non-affiliated centers through its SunDance subsidiary, medical staffing services through its CareerStaff Unlimited subsidiary and hospice services through its SolAmor subsidiary.

Forward-Looking Statements

Statements made in this release that are not historical facts are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995) that involve risks and uncertainties and are subject to change at any time. These forward-looking statements may include, but are not limited to, statements containing words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “hope,” “intend,” “may” and similar expressions. Factors that could cause actual results to differ are identified in the public filings made by the Company with the Securities and Exchange Commission and include our ability to successfully complete the offering on terms and conditions satisfactory to us, as well as other risks and uncertainties, including those detailed from time to time in our Securities and Exchange Commission filings. More information on factors that could affect our business and financial results are included in our public filings made with the Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, copies of which are available on Sun’s web site, www.sunh.com. The forward-looking statements involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond our control. We caution investors that any forward-looking statements made by Sun are not guarantees of future performance. We disclaim any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

NORMAN, OK–(Marketwire – August 12, 2010) – Access Plans, Inc. (OTCBB: APNC), a leading membership benefits marketing company, today announced that the Company will host an investor conference call to discuss its operating results for the third quarter and first nine months of FY2010 at 11:30 a.m. Eastern Time (EDT) on Monday, August 16, 2010. The Company will release its operating results earlier the same day.

Shareholders and other interested parties may participate in the conference call by dialing 877-317-6789 (international/local participants dial 412-317-6789) and asking to be connected to the “Access Plans, Inc. Conference Call” a few minutes before 11:30 a.m. EDT on August 16, 2010. The conference call will also be available via “live” webcast under the Investor Relations section of the Company’s website at www.accessplans.com, or by visiting http://www.videonewswire.com/event.asp?id=71766  to access the webcast directly.

A replay of the conference call will be available one hour after the call through Tuesday, August 24, 2010 at 9:00 a.m. EDT by dialing 877-344-7529 (U.S.) or 412-317-0088 (international) and entering the conference ID Number 443633.

An archived version of the webcast will also be available under the Investor Relations section of the Company’s website at www.accessplans.com.

About Access Plans, Inc.

Access Plans, Inc. (OTCBB: APNC) is a leading membership benefits marketing company with two distribution channels. The Wholesale/Retail Plans distribution channel specializes in turnkey, private-label membership benefit plans that provide discount products and services, protection benefits and retail services to more than 1 million customers in the United States and Canada. America’s Health Care Plans (AHCP), the Company’s Insurance Marketing distribution channel, is one of the nation’s largest independent agent networks and provides major medical, life and supplemental insurance products to individuals. For more information, please visit: www.accessplans.com.

LAGUNA HILLS, CA–(Marketwire – August 11, 2010) –  Today, Iconosys, Inc., a leader in mobile communications technology, announces a first in terms of integrating the world’s primary new means of communication, text messaging, with the needs of professionals in Real Estate, Medical Offices, Dental Offices, and for appointment setters of all types.

Originally a research and development project designed to explore possibilities and further enhance the wildly popular texting while driving apps already offered by Iconosys’ SMS Replier™ (www.smsreplier.com) and DriveReply™ (www.drivereply.net) products, Mighty SMS™ has now evolved into a text message scheduling system that allows professionals to setup reminders for their clients and patients and enables them to send their clients and customers friendly courtesy notices/reminders prior to their scheduled meetings and thank you notes afterward.

Mighty SMS™ comes in a personal version, where all features are managed on the phone itself, or in a professional version with more functionality; the app can be administered through an internet interface, and scheduling can be done in real time (right in front of the patient, or while on the phone with a sales lead) and as your appointments are being scheduled. The web interface/management comes at a nominal monthly fee. Also, while the company is excited about its plans for integration of this app into Google Calendar and Outlook in the near future as a plug-in for ease of management by office staff and appointment setters, at present Mighty SMS™ is fully functional and ready to meet the heavy demands of the busy professional or house-spouse.

As of now, a personal user can use it to pre-program text message salutations to their friends, loved ones, and professional contacts. Thank You’s, Happy Birthday’s, and Happy Anniversary’s are not accidentally forgotten when you input your Mighty SMS™ onto your phone and utilize this to organize your calendar and your contacts.

In the Professional version, customized replies can be generated that remind clients and patients of upcoming appointments, with information about contacting you back if there are any changes. 

“Already a favorite among dentists here in Orange County, CA, the dentists are seeing a lower volume of cancellations and ‘forgetting’s,’ as patients that made appointments sometimes months earlier, and may have completely forgotten their appointment, get a friendly non-threatening personal message from their favorite service provider (dentist, doctor, optometrist, hairstylist, chiropractor, contractor, MONAVIE rep, etc.),” commented Wayne Irving, CEO of Iconosys, Inc. Mr. Irving continued, “It’s great for car salesmen or others in sales that want to pre-program a thank you message for a couple days later after the sale, to send good wishes and work for that return customer and high rating of customer satisfaction.”

Texting or text messaging has become a significant portion of our population’s first means of communication. Less formal than an email, more convenient than a phone call or voicemail, and more secure than instant messaging, text messaging has become our tool for meaningful introductions when two people wish to express or share short messages without getting into deep conversations, for reasons like lack of time, while still providing a sense of personal fulfillment and significance to the recipient for the “thought that counted” when they receive a wish for good tidings.

Text messaging is a great way to share short personal bits of data between people that share responsibilities, like parents and or partners in a company. It’s a great way to send addresses and other short bits of info that do not require a full conversation, and without the risk of leaving a voicemail that may not get listened to for days and days.

“I use text messaging for every possible communication I can. It allows me to talk to more people, get more done in less time, and keep tabs on my employees, without having to go through all the greetings and salutations and small talk all the time. I don’t do it ALL the time, but it sure helps me to build my business and be more productive wherever I am, while also allowing me to regularly and consistently stay in touch with the people I work with and to convey a ‘job-well-done’ or to give them constructive advice where appropriate,” said Jeffrey Weiss, CTO for Iconosys, Inc.

Mighty SMS™ is available to the personal User for $3.99 per month, and for the Business or Professional user at $59.99 per year. The integrated web interface tools are scheduled to be made available in September for Professional users only at a $39 per month maintenance fee. Professional users price includes 60 minutes of tech support per year for setup, changes, and migration advice. The service currently requires a Windows Mobile 6.5 or Windows Phone 7. The company plans to offer this product on the Android platform when the Android Tablet is released closer to Christmas 2010.

Mighty SMS™ is pending availability on the Windows Marketplace, but until then it can be downloaded from www.Handango.com, www.CNET.com, www.PayLoadz.com and www.MightySMS.com.

About Iconosys, Inc.

Iconosys, Inc. is developing a series of technologies designed to make mobile applications better, faster, easier, and ultimately safer to use. Iconosys’ flagship product, SMS Replier™, is a revolutionary mobile phone application designed to couple many convenience services with addressing the growing problem of communicating safely while driving a car, truck, or motorcycle.

Iconosys’ CEO Wayne Irving II, a pioneer in next-generation telecom concepts, has led the drive to take advantage of GPS and other onboard motion technologies to build lifesaving and life-enhancing products and utilities, and to create new and better tools for wireless platforms and mobile device operating systems.

Iconosys proprietary technology, developed with support from Motorola, is a complex series of algorithms and readings from the technology running on today’s Smartphones; this includes, without limitation, GPS and other motion sensoring, coordinated with Google mapping to provide an accurate and responsive background service to most, if not all, of the upcoming Iconosys technology releases. Iconosys’ DriveReply™ technology tests up to 90% more efficient in battery consumption while using ordinary GPS technology, a key differentiator for Iconosys, when competing with other producers of GPS dependent Smartphone applications. 

For more information, including demonstration videos, on Iconosys, Inc, please visit: http://www.iconosys.com or http://www.mightysms.com. 

For further information about Iconosys, Inc. and its products or for interviews with CEO Wayne Irving II, please contact Adam Mazur at 212-843-8073 or [email protected]. High-resolution images and instructional videos available upon request. Follow Mighty SMS™ on twitter: @mightysms

Click here to see all recent news from this company

VANCOUVER, BRITISH COLUMBIA–(Marketwire – Aug. 10, 2010) –

(NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA)

Medifocus Inc. (TSX VENTURE:MFS)(PINK SHEETS:MDFZF) (“Medifocus” or the “Company”) announces the completion of a private placement of 2,449,997 Units (the “Units”) at a price of $0.30 per Unit for gross proceeds of $734,999. Each unit is comprised of one Common Share and one Series A Common Share purchase warrant. Each Series A Common Share purchase warrant will entitle the holder to purchase one additional Common Share at a price of $0.50 for a period of 24 months following the closing of the offering. If, at any time prior to April 26, 2012, the daily volume weighted average trading price of the Company’s common shares on the TSX Venture Exchange exceeds $0.75 for at least 10 consecutive trading days, the Company may, within 30 days of such occurrence, give an expiry acceleration notice to the holders of warrants and, if it does so, the warrants will, unless exercised, expire on the 30th day after the expiry acceleration notice is given.

Securities issued in connection with the private placement and any shares issued upon the exercise of the warrants will have a hold period in Canada until December 7, 2010.

The net proceeds of this offering will be primarily used to initiate a pivotal phase III clinical trial using the Company’s Microfocus APA 1000 System for the treatment of breast cancer (including all related professional expenses) and for working capital.

Medifocus also announces that it is in the process of finalizing the previously announced debt settlement with certain third party creditors, employees and service providers. Subject to approval by the TSX Venture Exchange, Medifocus will issue an aggregate of 3,592,105 common shares at an aggregate deemed price of $0.50 per common share to settle such outstanding debt. The common shares issued will be subject to hold periods pursuant to applicable securities laws as well as the policies of the TSX Venture Exchange.

Medifocus owns a patented microwave focusing technology platform (the Adaptive Phased Array (“APA”) technology), which can precisely target and control microwave energy to cause heating in cancerous tumors anywhere in the body reliably and repeatedly. The ability to target tumors with a precision controlled dose of heat can be used to destroy tumors at higher temperatures, to treat tumors in combination with chemotherapy and/or radiation at moderate temperatures for increased effectiveness and reduced toxicity and to trigger the targeted release of therapeutic drugs and genes at tumor sites at lower temperatures. While the core technology has been licensed from the Massachusetts Institute of Technology, Medifocus has further refined the precision of the microwave focusing and control ability and developed a commercial system dedicated exclusively for the treatment of Breast Cancer. Please visit www.medifocusinc.com for more details.

PHOENIX, AZ–(Marketwire – August 10, 2010) –  VALLEYLIFE, a not for profit organization committed to serving individuals with developmental disabilities, launched a sponsorship program to benefit its disabled members and invites the public to attend an open house. For more than 63 years, VALLEYLIFE has provided services to its disabled members so they might not only meet daily essential needs, but to achieve a brighter future with programs that support job training, housing, social activities, and independent living skills. 

Due to a recent termination in state funding, more than 700 disabled citizens in Arizona have been cut from their programs. At VALLEYLIFE, 17 members are directly affected and no longer receive government funding. Despite this, the staff at VALLEYLIFE has continued to provide its members the ongoing support they need. 

“Most of the members directly affected have no family. The staff at VALLEYLIFE has become their family and they, a part of ours. We will continue to provide the programs as long as we can, but without appropriate services, some of our disabled members may end up on the street or in jail,” said Cletus Thiebeau, CEO of VALLEYLIFE.

VALLEYLIFE’s sponsorship program enables local business and private citizens an opportunity to support the community they live in by providing our members with services they need to be independent. The cost to sponsor a member for one hour of service is $4, the cost of a gourmet cup of coffee. The programs range from vocational services where a member is able to earn money, to day treatment program services, where a developmentally disabled member is under the care of a qualified staff member.

VALLEYLIFE prides itself in its low administrative cost of 7 percent; 93 cents of every dollar goes directly into the programs, directly making a difference in the lives of its members. Their motto is: Changing lives. Creating Community. Today, VALLEYLIFE is humbly turning to its community for financial support so that their organization can continue to provide services to a population of people often forgotten, developmentally disabled adults.

Please show your support by calling in a monthly pledge or sending in a one-time donation. The staff at VALLEYLIFE also welcomes the public to an open house at their facility. Donors will see first-hand how even the most modest financial donation goes a long way, directly touching the lives of those who need immediate help and care.

To learn more about VALLEYLIFE, please visit www.VALLEYLIFEaz.org

Click here to see all recent news from this company

AUSTIN, TX–(Marketwire – August 10, 2010) –  As a recognized leader in the business of medical and radiation oncology, Revenue Cycle Inc. announces a new partnership with The Oncology Group. The affiliation continues a growing trend for Revenue Cycle, known for its broad-based oncology consulting work and education and training services.

As one of the premier cancer care consulting organizations in the nation, The Oncology Group will join the 3 core businesses that are Revenue Cycle: RC Billing for medical practice coding, billing, insurance submissions and AR management; Revenue Cycle consulting services which offer complete audits to measure charge capture accuracy and standards compliance; and NDevor, a healthcare facilities development company.

“We are pleased to add The Oncology Group as an affiliate and look forward to the continued growth of our companies,” says Revenue Cycle Inc. Chief Executive Officer Ron DiGiaimo. “Recognizing a need for a ‘best of the best’ is part of the company culture, and dictates everything Revenue Cycle does on a daily basis; the merger will increase our combination of resources and expertise.”

President of The Oncology Group Marsha Fountain adds, “The Oncology Group will continue its tradition of customized oncology services consulting and strategic planning for community and academic cancer centers. Our relationship with Revenue Cycle Inc., and their position as a key source of thought leadership within the physician practice arena increases both firms’ influence within an integrating cancer services market.”

The combined activities of both companies will continue The Oncology Group’s focus on all aspects of oncology growth and business management. Leaders from both merger partners agree that the strategic alliance will benefit their clients, as hospitals work to create and sustain integrated 21st century cancer centers and physician practices. For more information about Revenue Cycle Inc., please visit www.revenuecycleinc.com. To contact The Oncology Group visit www.theoncologygroup.com.

WINNIPEG, MANITOBA–(Marketwire – Aug. 10, 2010) – DiaMedica Inc. (TSX VENTURE:DMA) today announced the appointment of Dr. Michael Giuffre to the company’s Board of Directors.

Dr. Giuffre is a Clinical Professor of Cardiac Sciences and Pediatrics at the University of Calgary. Dr Giuffre is currently a member on the board’s of the Alberta Medical Association and Unicef Canada. He is a past representative to the board of the Calgary Health Region and is an active participant in the biotechnology business sector.

“Dr. Giuffre’s clinical and business experience, particularly with his extensive cardiovascular background, will add additional depth to our Board,” stated Mr. Rick Pauls, President and CEO of DiaMedica.

“I am pleased to be joining the Board of Directors of DiaMedica at such a progressive time in its history,” stated Dr. Giuffre. “DiaMedica has very promising technology and I look forward to leveraging my experience as the company prepares for exciting and ambitious milestones.”

About Dr. Michael Giuffre

As a Clinical Professor of Cardiac Sciences and Pediatrics at the University of Calgary, Dr Giuffre maintains a portfolio of clinical practice, cardiovascular research, and university teaching. He maintains on-going involvement in both health care administration, and in the biotechnology business sector. Dr Giuffre is Past President of the Calgary and Area Physicians Association (CAPA) and a past representative to the board of the Calgary Health Region. Dr Giuffre holds a BSc in cellular and microbial biology, a PhD candidacy in molecular virology, an MD and an MBA. His Canadian Royal College board certified specialties include Pediatrics, Pediatric Cardiology and a subspecialty in Pediatric Electrophysiology.

As a biotechnology consultant, Dr. Giuffre has been involved with RedSky Inc. (acquired by Research in Motion), MDMI, and MedMira Inc. He is currently on the boards of IC2E Inc and FoodChek Inc. He serves on the Medical Advisory Board of the SADS Foundation and on the boards of Unicef Canada and the Alberta Medical Association. He is also an MD-MP contact for the Canadian Medical Association.

Dr Giuffre has recently received a Certified and Registered Appointment by the American Academy of Cardiology, “Distinguished Fellow of the American Academy of Cardiology,” and in 2005 was awarded “Physician of the Year” by the Calgary Medical Society.

About DiaMedica

DiaMedica is a biopharmaceutical company focused on developing novel treatments for diabetes and neurological disorders. The Company’s type 2 diabetes program is based on a critical liver nerve signaling mechanism involved in enhancing insulin sensitivity after meal consumption. Two of DiaMedica’s products, DM-71 and DM-99, have previously demonstrated human efficacy in lowering blood sugar levels in people diagnosed with type 2 diabetes based on this novel nerve signaling mechanism.

DiaMedica has expanded its DM-199 recombinant protein program into neurological and autoimmune disorders. The Company has demonstrated that DM-99, the naturally occurring form of DM-199, confers neural protection (protects brain cells) and triggers neural stem cell proliferation (creates brain cells) for the treatment of numerous neurological disorders including Alzheimer’s disease. DiaMedica is listed on the TSX Venture Exchange under the trading symbol “DMA”. For further information please visit www.diamedica.com.

Caution Regarding Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable Canadian provincial securities legislation (collectively, the “forward-looking statements“). These forward-looking statements relate to, among other things, DiaMedica’s objectives, goals, targets, strategies, intentions, plans, beliefs, estimates and outlook, and can, in some cases, be identified by the use of words such as “believe,” “anticipate,” “expect,” “intend,” “plan,” “will,” “may” and other similar expressions. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements. Specifically, this press release contains forward-looking statements regarding matters such as, but not limited to, the prospective Offering and the proceeds from the Offering, the anticipated use of proceeds from the Offering, regulatory approval of the Offering, and our other plans, estimates and expectations, including the completion of our proposed acquisition of Sanomune Inc. These statements reflect management’s current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Important factors that could cause actual results to differ materially from these expectations include, among other things: uncertainties and risks related to our ability to complete the Offering, the availability of financing, risks and uncertainties relating to the anticipated use of proceeds, changes in debt and equity markets, uncertainties related to clinical trials and product development, rapid technological change, uncertainties related to forecasts, competition, potential product liability, additional financing requirements and access to capital, unproven markets, the cost and supply of raw materials, management of growth, effects of insurers’ willingness to pay for products, risks related to regulatory matters and risks related to intellectual property matters. 
Additional information about these factors and about the material factors or assumptions underlying such forward-looking statements may be found in the body of this news release, as well as under the heading “Risk Factors” contained in DiaMedica’s 2008 annual information form. DiaMedica cautions that the foregoing list of important factors that may affect future results is not exhaustive. When relying on DiaMedica’s forward-looking statements to make decisions with respect to DiaMedica, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. Such forward-looking statements are based on a number of estimates and assumptions which may prove to be incorrect, including, but not limited to, assumptions regarding the availability of financing for research and development companies, general business and economic conditions, and DiaMedica’s ability to complete its proposed acquisition of Sanomune Inc. These risks and uncertainties should be considered carefully and investors and others should not place undue reliance on the forward-looking statements. Although the forward-looking statements contained in this press release are based upon what management believes to be reasonable assumptions, DiaMedica cannot provide assurance that actual results will be consistent with these forward-looking statements. DiaMedica undertakes no obligation to update or revise any forward-looking statement. Additional risk factors, factors which could cause actual results to differ materially from expectations, and assumptions relating specifically to our proposed acquisition of Sanomune Inc. may be found in our press release dated February 18, 2010.